Medtech, a company specialized in designing, developing and marketing innovative surgical assistance robots, is pleased to announce that it has received 510K clearance from the United States Food and Drug Administration (FDA) to market the ROSA™ Spine robot in the United States of America.
Obtaining FDA clearance is a major step in Medtech's development strategy and will allow the Company to market the ROSA™ Spine robot in the United States for minimally invasive surgical procedures on the spine. Around 3 million such procedures are performed worldwide each year.
Bertin Nahum, CEO and Founder of Medtech, said: "We are thrilled to have FDA approval for ROSA™ Spine.
